Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

EPA:AKE - Euronext Paris - Matif - FR0010313833 - Common Stock - Currency: EUR

66  +0.6 (+0.92%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AKE. AKE was compared to 61 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE has a correct valuation and a medium growth rate. AKE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
In the past year AKE had a positive cash flow from operations.
In the past 5 years AKE has always been profitable.
In the past 5 years AKE always reported a positive cash flow from operatings.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

AKE's Return On Assets of 2.22% is fine compared to the rest of the industry. AKE outperforms 60.66% of its industry peers.
AKE's Return On Equity of 4.49% is in line compared to the rest of the industry. AKE outperforms 59.02% of its industry peers.
AKE has a better Return On Invested Capital (3.98%) than 65.57% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AKE is in line with the industry average of 6.81%.
Industry RankSector Rank
ROA 2.22%
ROE 4.49%
ROIC 3.98%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 3.54%, AKE is in the better half of the industry, outperforming 60.66% of the companies in the same industry.
In the last couple of years the Profit Margin of AKE has declined.
The Operating Margin of AKE (7.52%) is better than 68.85% of its industry peers.
AKE's Operating Margin has declined in the last couple of years.
AKE's Gross Margin of 20.32% is on the low side compared to the rest of the industry. AKE is outperformed by 65.57% of its industry peers.
AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.52%
PM (TTM) 3.54%
GM 20.32%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, AKE has more shares outstanding
AKE has less shares outstanding than it did 5 years ago.
AKE has a worse debt/assets ratio than last year.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.80, we must say that AKE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.80, AKE is not doing good in the industry: 62.30% of the companies in the same industry are doing better.
The Debt to FCF ratio of AKE is 12.65, which is on the high side as it means it would take AKE, 12.65 years of fcf income to pay off all of its debts.
AKE has a Debt to FCF ratio (12.65) which is comparable to the rest of the industry.
AKE has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
AKE's Debt to Equity ratio of 0.49 is in line compared to the rest of the industry. AKE outperforms 49.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 12.65
Altman-Z 1.8
ROIC/WACC0.78
WACC5.13%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.01 indicates that AKE has no problem at all paying its short term obligations.
AKE has a better Current ratio (2.01) than 65.57% of its industry peers.
AKE has a Quick Ratio of 1.47. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
AKE has a better Quick ratio (1.47) than 70.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.47
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The earnings per share for AKE have decreased by -6.06% in the last year.
AKE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.10% yearly.
The Revenue has been growing slightly by 0.32% in the past year.
AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-6.06%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-10.56%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%2.07%

3.2 Future

The Earnings Per Share is expected to grow by 8.55% on average over the next years. This is quite good.
AKE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.13% yearly.
EPS Next Y-2.71%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
EPS Next 5Y8.55%
Revenue Next Year5.03%
Revenue Next 2Y4.59%
Revenue Next 3Y4.21%
Revenue Next 5Y4.13%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.04, the valuation of AKE can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of AKE indicates a rather cheap valuation: AKE is cheaper than 93.44% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.79. AKE is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 8.26, the valuation of AKE can be described as reasonable.
AKE's Price/Forward Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 91.80% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, AKE is valued rather cheaply.
Industry RankSector Rank
PE 8.04
Fwd PE 8.26
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKE is valued cheaply inside the industry as 88.52% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKE indicates a somewhat cheap valuation: AKE is cheaper than 77.05% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.94
EV/EBITDA 4.92
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)82.26
EPS Next 2Y5.68%
EPS Next 3Y6.35%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.87%, AKE is a good candidate for dividend investing.
AKE's Dividend Yield is rather good when compared to the industry average which is at 3.25. AKE pays more dividend than 93.44% of the companies in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 5.87%

5.2 History

The dividend of AKE is nicely growing with an annual growth rate of 6.86%!
Dividend Growth(5Y)6.86%
Div Incr Years3
Div Non Decr Years3
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AKE pays out 77.22% of its income as dividend. This is not a sustainable payout ratio.
The dividend of AKE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP77.22%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (4/25/2025, 7:00:00 PM)

66

+0.6 (+0.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners52.1%
Inst Owner ChangeN/A
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap5.02B
Analysts80.91
Price Target105.12 (59.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.87%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP77.22%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.09%
Min EPS beat(2)-18.44%
Max EPS beat(2)-1.73%
EPS beat(4)2
Avg EPS beat(4)-0.7%
Min EPS beat(4)-18.44%
Max EPS beat(4)8.93%
EPS beat(8)5
Avg EPS beat(8)1.72%
EPS beat(12)9
Avg EPS beat(12)9.54%
EPS beat(16)13
Avg EPS beat(16)15.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-0.57%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)3.26%
Revenue beat(8)2
Avg Revenue beat(8)-1.34%
Revenue beat(12)6
Avg Revenue beat(12)0.07%
Revenue beat(16)10
Avg Revenue beat(16)1.27%
PT rev (1m)-1.32%
PT rev (3m)-3.74%
EPS NQ rev (1m)-18.2%
EPS NQ rev (3m)-33.17%
EPS NY rev (1m)-16.29%
EPS NY rev (3m)-21.09%
Revenue NQ rev (1m)-2.31%
Revenue NQ rev (3m)-4.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 8.04
Fwd PE 8.26
P/S 0.53
P/FCF 13.94
P/OCF 4.48
P/B 0.67
P/tB 2.41
EV/EBITDA 4.92
EPS(TTM)8.21
EY12.44%
EPS(NY)7.99
Fwd EY12.1%
FCF(TTM)4.73
FCFY7.17%
OCF(TTM)14.74
OCFY22.33%
SpS125.48
BVpS98.95
TBVpS27.37
PEG (NY)N/A
PEG (5Y)82.26
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 4.49%
ROCE 5.64%
ROIC 3.98%
ROICexc 4.74%
ROICexgc 9.65%
OM 7.52%
PM (TTM) 3.54%
GM 20.32%
FCFM 3.77%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexcg growth 3Y-19.33%
ROICexcg growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 12.65
Debt/EBITDA 2.42
Cap/Depr 94.89%
Cap/Sales 7.97%
Interest Coverage 44.88
Cash Conversion 73.75%
Profit Quality 106.51%
Current Ratio 2.01
Quick Ratio 1.47
Altman-Z 1.8
F-Score4
WACC5.13%
ROIC/WACC0.78
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.06%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-10.56%
EPS Next Y-2.71%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
EPS Next 5Y8.55%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%2.07%
Revenue Next Year5.03%
Revenue Next 2Y4.59%
Revenue Next 3Y4.21%
Revenue Next 5Y4.13%
EBIT growth 1Y-11.47%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year79.11%
EBIT Next 3Y27.21%
EBIT Next 5Y17.14%
FCF growth 1Y-39.39%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-11.87%
OCF growth 3Y7%
OCF growth 5Y-2.92%